Session

H.pylori: Extra-digestive manifestations and therapy

DIABETES LEADS TO A DECREASE IN THE ERADICATION RATE OF HELICOBACTER PYLORI
DIABETES LEADS TO A DECREASE IN THE ERADICATION RATE OF HELICOBACTER PYLORI

RISKS OF MAJOR OSTEOPOROTIC FRACTURE IN PATIENTS WHO FAILED H. PYLORI ERADICATION THERAPY: A POPULATION-BASED STUDY
RISKS OF MAJOR OSTEOPOROTIC FRACTURE IN PATIENTS WHO FAILED H. PYLORI ERADICATION THERAPY: A POPULATION-BASED STUDY

TIMING OF PREVIOUS EXPOSURE TO ANTIBIOTICS AND FAILURE OF CLARITHROMYCIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A POPULATION-BASED STUDY
TIMING OF PREVIOUS EXPOSURE TO ANTIBIOTICS AND FAILURE OF CLARITHROMYCIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A POPULATION-BASED STUDY

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

ASSESSMENT OF PATIENTS AT-RISK FOR HELICOBACTER PYLORI INFECTION USING MEDICAL INSURANCE CLAIMS DATA AND MACHINE LEARNING
ASSESSMENT OF PATIENTS AT-RISK FOR HELICOBACTER PYLORI INFECTION USING MEDICAL INSURANCE CLAIMS DATA AND MACHINE LEARNING

ASSESSMENT OF PATIENTS AT-RISK FOR HELICOBACTER PYLORI INFECTION USING MEDICAL INSURANCE CLAIMS DATA AND MACHINE LEARNING
ASSESSMENT OF PATIENTS AT-RISK FOR HELICOBACTER PYLORI INFECTION USING MEDICAL INSURANCE CLAIMS DATA AND MACHINE LEARNING

H.pylori: Extra-digestive manifestations and therapy  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H.pylori: Extra-digestive manifestations and therapy  et al.

TIMING OF PREVIOUS EXPOSURE TO ANTIBIOTICS AND FAILURE OF CLARITHROMYCIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A POPULATION-BASED STUDY
TIMING OF PREVIOUS EXPOSURE TO ANTIBIOTICS AND FAILURE OF CLARITHROMYCIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A POPULATION-BASED STUDY

H.pylori: Extra-digestive manifestations and therapy  et al.

RISKS OF MAJOR OSTEOPOROTIC FRACTURE IN PATIENTS WHO FAILED H. PYLORI ERADICATION THERAPY: A POPULATION-BASED STUDY
RISKS OF MAJOR OSTEOPOROTIC FRACTURE IN PATIENTS WHO FAILED H. PYLORI ERADICATION THERAPY: A POPULATION-BASED STUDY

H.pylori: Extra-digestive manifestations and therapy  et al.

DIABETES LEADS TO A DECREASE IN THE ERADICATION RATE OF HELICOBACTER PYLORI
DIABETES LEADS TO A DECREASE IN THE ERADICATION RATE OF HELICOBACTER PYLORI

H.pylori: Extra-digestive manifestations and therapy  et al.

Item 1 - 10 / 10
1